CHRS Annual Accounts Payable
$35.22 M
+$23.69 M+205.56%
31 December 2023
Summary:
As of January 23, 2025, CHRS annual accounts payable is $35.22 million, with the most recent change of +$23.69 million (+205.56%) on December 31, 2023. During the last 3 years, it has risen by +$20.02 million (+131.69%). CHRS annual accounts payable is now at all-time high.CHRS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS Quarterly Accounts Payable
$21.89 M
-$54.92 M-71.50%
30 September 2024
Summary:
As of January 23, 2025, CHRS quarterly accounts payable is $21.89 million, with the most recent change of -$54.92 million (-71.50%) on September 30, 2024. Over the past year, it has dropped by -$15.20 million (-40.98%). CHRS quarterly accounts payable is now -71.50% below its all-time high of $76.82 million, reached on June 30, 2024.CHRS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +205.6% | -41.0% |
| 3 y3 years | +131.7% | -25.2% |
| 5 y5 years | +130.3% | -25.2% |
CHRS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +205.6% | -71.5% | +120.8% |
| 5 y | 5-year | at high | +205.6% | -71.5% | +120.8% |
| alltime | all time | at high | +855.7% | -71.5% | +494.1% |
Coherus BioSciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.89 M(-71.5%) |
| June 2024 | - | $76.82 M(+100.6%) |
| Mar 2024 | - | $38.29 M(+8.7%) |
| Dec 2023 | $35.22 M(+205.6%) | $35.22 M(-5.0%) |
| Sept 2023 | - | $37.09 M(+26.7%) |
| June 2023 | - | $29.28 M(+26.0%) |
| Mar 2023 | - | $23.23 M(+101.6%) |
| Dec 2022 | $11.53 M(-28.7%) | $11.53 M(+16.2%) |
| Sept 2022 | - | $9.92 M(-43.3%) |
| June 2022 | - | $17.49 M(-17.1%) |
| Mar 2022 | - | $21.09 M(+30.5%) |
| Dec 2021 | $16.16 M(+6.3%) | $16.16 M(-64.6%) |
| Sept 2021 | - | $45.71 M(+213.7%) |
| June 2021 | - | $14.57 M(-5.9%) |
| Mar 2021 | - | $15.48 M(+1.8%) |
| Dec 2020 | $15.20 M(-41.5%) | $15.20 M(+26.8%) |
| Sept 2020 | - | $11.99 M(-43.4%) |
| June 2020 | - | $21.18 M(+3.4%) |
| Mar 2020 | - | $20.48 M(-21.2%) |
| Dec 2019 | $25.98 M | $25.98 M(+89.5%) |
| Sept 2019 | - | $13.71 M(-28.9%) |
| June 2019 | - | $19.27 M(+72.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $11.17 M(-26.9%) |
| Dec 2018 | $15.29 M(-2.7%) | $15.29 M(+100.3%) |
| Sept 2018 | - | $7.64 M(-42.6%) |
| June 2018 | - | $13.30 M(-7.4%) |
| Mar 2018 | - | $14.37 M(-8.6%) |
| Dec 2017 | $15.71 M(-23.7%) | $15.71 M(+54.9%) |
| Sept 2017 | - | $10.14 M(-37.1%) |
| June 2017 | - | $16.14 M(+10.0%) |
| Mar 2017 | - | $14.67 M(-28.7%) |
| Dec 2016 | $20.58 M(-30.2%) | $20.58 M(-20.0%) |
| Sept 2016 | - | $25.74 M(+29.6%) |
| June 2016 | - | $19.86 M(-7.2%) |
| Mar 2016 | - | $21.40 M(-27.5%) |
| Dec 2015 | $29.50 M(+173.2%) | $29.50 M(+4.3%) |
| Sept 2015 | - | $28.28 M(+44.3%) |
| June 2015 | - | $19.60 M(+34.3%) |
| Mar 2015 | - | $14.59 M(+35.2%) |
| Dec 2014 | $10.80 M(+193.0%) | $10.80 M(+15.2%) |
| Sept 2014 | - | $9.37 M(+11.4%) |
| June 2014 | - | $8.41 M(+128.4%) |
| Dec 2013 | $3.69 M(-5.6%) | $3.69 M |
| Dec 2012 | $3.90 M | - |
FAQ
- What is Coherus BioSciences annual accounts payable?
- What is the all time high annual accounts payable for Coherus BioSciences?
- What is Coherus BioSciences annual accounts payable year-on-year change?
- What is Coherus BioSciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Coherus BioSciences?
- What is Coherus BioSciences quarterly accounts payable year-on-year change?
What is Coherus BioSciences annual accounts payable?
The current annual accounts payable of CHRS is $35.22 M
What is the all time high annual accounts payable for Coherus BioSciences?
Coherus BioSciences all-time high annual accounts payable is $35.22 M
What is Coherus BioSciences annual accounts payable year-on-year change?
Over the past year, CHRS annual accounts payable has changed by +$23.69 M (+205.56%)
What is Coherus BioSciences quarterly accounts payable?
The current quarterly accounts payable of CHRS is $21.89 M
What is the all time high quarterly accounts payable for Coherus BioSciences?
Coherus BioSciences all-time high quarterly accounts payable is $76.82 M
What is Coherus BioSciences quarterly accounts payable year-on-year change?
Over the past year, CHRS quarterly accounts payable has changed by -$15.20 M (-40.98%)